SWKH RSI Chart
Last 7 days
-1.5%
Last 30 days
-0.1%
Last 90 days
3.8%
Trailing 12 Months
2.1%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 40.6M | 39.6M | 38.7M | 37.8M |
2022 | 52.5M | 48.8M | 45.2M | 41.5M |
2021 | 41.6M | 46.4M | 51.3M | 56.2M |
2020 | 32.7M | 34.7M | 0 | 36.7M |
2019 | 28.6M | 27.4M | 29.1M | 30.7M |
2018 | 29.4M | 30.1M | 30.5M | 26.0M |
2017 | 32.0M | 29.5M | 30.7M | 37.5M |
2016 | 22.9M | 26.1M | 24.6M | 22.4M |
2015 | 19.5M | 21.6M | 23.6M | 23.5M |
2014 | 9.7M | 12.0M | 14.2M | 17.4M |
2013 | 1.1M | 2.0M | 3.5M | 6.4M |
2012 | 244.0K | 220.0K | 205.0K | 682.0K |
2011 | 468.5K | 407.0K | 345.5K | 284.0K |
2010 | 0 | 0 | 0 | 530.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 01, 2024 | albright jerry | acquired | 13,757 | 16.88 | 815 | - |
Apr 01, 2024 | hatcher robert k. | acquired | 13,757 | 16.88 | 815 | - |
Apr 01, 2024 | pennington marcus edward | acquired | 31,498 | 16.88 | 1,866 | - |
Apr 01, 2024 | dotter laurie l. | acquired | 13,757 | 16.88 | 815 | - |
Mar 01, 2024 | staggs joe david jr | acquired | - | - | 35,881 | president |
Jan 02, 2024 | hatcher robert k. | acquired | 13,749 | 17.95 | 766 | - |
Jan 02, 2024 | pennington marcus edward | acquired | 27,499 | 17.95 | 1,532 | - |
Jan 02, 2024 | dotter laurie l. | acquired | 13,749 | 17.95 | 766 | - |
Jan 02, 2024 | albright jerry | acquired | 13,749 | 17.95 | 766 | - |
Oct 02, 2023 | pennington marcus edward | acquired | 31,509 | 15.85 | 1,988 | - |
Which funds bought or sold SWKH recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | COMERICA BANK | sold off | -100 | -3,173 | - | -% |
May 16, 2024 | SkyView Investment Advisors, LLC | new | - | 504,000 | 504,000 | 0.09% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -39.04 | -4,196 | 6,445 | -% |
May 15, 2024 | Royal Bank of Canada | reduced | -10.58 | -27,000 | 214,000 | -% |
May 15, 2024 | GOLDMAN SACHS GROUP INC | reduced | -0.56 | -2,810 | 233,933 | -% |
May 15, 2024 | CANNELL CAPITAL LLC | reduced | -17.22 | -2,560,930 | 11,877,700 | 2.55% |
May 15, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | added | 3.5 | 52,483 | 1,890,800 | 0.04% |
May 15, 2024 | PERRITT CAPITAL MANAGEMENT INC | unchanged | - | -2,200 | 348,400 | 0.19% |
May 15, 2024 | BARCLAYS PLC | reduced | -44.87 | -42,000 | 50,000 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | reduced | -57.38 | -72,967 | 53,600 | -% |
Unveiling SWK Holdings Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to SWK Holdings Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
BLK | 120.7B | 18.3B | 20.39 | 6.58 | ||||
BX | 89.8B | 10.3B | 41.74 | 8.7 | ||||
ARES | 45.1B | 3.6B | 95.05 | 12.68 | ||||
BK | 44.5B | 19.6B | 13.33 | 2.27 | ||||
BEN | 12.8B | 8.1B | 14.21 | 1.58 | ||||
MID-CAP | ||||||||
IVZ | 7.2B | 5.8B | -21.34 | 1.25 | ||||
AMG | 5.1B | 2.0B | 7.38 | 2.49 | ||||
AB | 3.9B | - | 14.21 | - | ||||
CNS | 3.7B | 486.3M | 28.98 | 7.61 | ||||
APAM | 3.6B | 1.0B | 15.6 | 3.59 | ||||
AMK | 2.5B | 722.2M | 17.56 | 3.5 | ||||
SMALL-CAP | ||||||||
PX | 948.7M | 250.6M | -360.78 | 3.79 | ||||
BSIG | 861.0M | 440.5M | 12.59 | 1.95 | ||||
AINC | 16.6M | 770.8M | -3.82 | 0.02 | ||||
AC | 733.0K | 23.1M | 0.02 | 0.03 |
SWK Holdings Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 19.1% | 12.00 | 10.00 | 9.00 | 9.00 | 9.00 | 10.00 | 14.00 | 12.00 | 11.00 | 11.00 | 10.00 | 10.00 | 9.00 | 9.00 | 8.00 | 7.00 | 7.00 | 6.00 | 6.00 | 9.00 | 7.00 |
Costs and Expenses | -347.4% | -1.47 | -0.33 | -4.33 | -4.67 | -5.32 | 4.00 | -6.76 | -1.74 | -5.29 | -49.89 | 7.00 | 6.00 | 6.00 | 8.00 | 9.00 | 8.00 | 9.00 | 3.00 | 1.00 | 2.00 | 1.00 |
S&GA Expenses | -100.0% | - | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | 4.00 | 3.00 | 3.00 | 4.00 | 4.00 | 3.00 | 3.00 | 2.00 | 3.00 | 3.00 | 2.00 | 3.00 | 1.00 | 1.00 | 1.00 |
R&D Expenses | -12.0% | 1.00 | 1.00 | 1.00 | 2.00 | 1.00 | 2.00 | 2.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | - | 0.00 | - | - | - |
EBITDA Margin | -13.1% | 0.44* | 0.50* | 0.34* | 0.44* | 0.31* | 0.30* | 0.56* | 0.40* | 0.70* | 0.67* | 0.66* | 0.80* | 0.53* | - | - | - | - | - | - | - | - |
Interest Expenses | 11.3% | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income Taxes | 110.3% | 0.00 | -2.23 | -0.39 | 1.00 | -0.11 | -7.21 | 2.00 | 0.00 | 1.00 | 2.00 | 1.00 | 4.00 | 1.00 | -1.34 | -1.00 | 1.00 | -8.16 | -0.61 | 1.00 | 1.00 | -0.36 |
Earnings Before Taxes | 78.4% | 1.00 | 1.00 | 4.00 | 5.00 | 5.00 | -4.38 | 9.00 | 1.00 | 5.00 | 8.00 | 3.00 | 17.00 | 4.00 | 3.00 | -0.12 | -3.41 | 1.00 | 4.00 | 5.00 | 8.00 | 4.00 |
EBT Margin | -23.5% | 0.30* | 0.39* | 0.25* | 0.36* | 0.23* | 0.23* | 0.49* | 0.34* | 0.63* | 0.59* | 0.54* | 0.63* | 0.27* | - | - | - | - | - | - | - | - |
Net Income | -69.7% | 1.00 | 3.00 | 4.00 | 4.00 | 5.00 | 3.00 | 7.00 | 1.00 | 3.00 | 6.00 | 2.00 | 14.00 | 3.00 | 5.00 | 1.00 | -4.66 | 9.00 | 4.00 | 4.00 | 7.00 | 5.00 |
Net Income Margin | -23.8% | 0.32* | 0.42* | 0.41* | 0.45* | 0.36* | 0.33* | 0.38* | 0.26* | 0.50* | 0.46* | 0.47* | 0.57* | 0.32* | - | - | - | - | - | - | - | - |
Free Cashflow | -19.5% | 4.00 | 6.00 | 4.00 | 5.00 | 1.00 | 3.00 | 2.00 | -0.86 | 4.00 | 11.00 | 4.00 | 15.00 | 4.00 | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -3.6% | 322 | 334 | 316 | 290 | 301 | 300 | 292 | 284 | 286 | 283 | 277 | 273 | 277 | 274 | 257 | 259 | 265 | 254 | 248 | 225 | 221 |
Current Assets | 17.4% | 14.00 | 12.00 | 37.00 | 13.00 | 9.00 | 10.00 | 28.00 | 59.00 | 46.00 | 47.00 | 25.00 | 13.00 | 7.00 | 7.00 | 17.00 | 23.00 | 29.00 | 16.00 | - | - | - |
Cash Equivalents | 22.1% | 5.00 | 5.00 | 31.00 | 7.00 | 3.00 | 6.00 | 19.00 | 55.00 | 41.00 | 43.00 | 19.00 | 7.00 | 2.00 | 3.00 | 9.00 | 17.00 | 24.00 | 11.00 | 4.00 | 27.00 | 39.00 |
Net PPE | -4.2% | 5.00 | 5.00 | 5.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 5.00 | 5.00 | 3.00 | 3.00 | 1.00 | 1.00 | 1.00 | - | - |
Goodwill | - | - | - | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 5.00 | - | - |
Liabilities | -22.0% | 42.00 | 54.00 | 38.00 | 17.00 | 26.00 | 20.00 | 15.00 | 13.00 | 15.00 | 15.00 | 16.00 | 15.00 | 33.00 | 33.00 | 21.00 | 27.00 | 33.00 | 18.00 | 20.00 | 1.00 | 2.00 |
Current Liabilities | 11.0% | 4.00 | 4.00 | 25.00 | 3.00 | 12.00 | 6.00 | 5.00 | 3.00 | 5.00 | 5.00 | 5.00 | 3.00 | 15.00 | 15.00 | 4.00 | 9.00 | 18.00 | 3.00 | - | - | - |
Shareholder's Equity | 0.0% | 280 | 280 | 278 | 274 | 274 | 280 | 277 | 272 | 271 | 267 | 261 | 258 | 244 | 241 | 236 | 232 | 232 | 237 | 228 | 223 | 219 |
Retained Earnings | 0.0% | -4,143 | -4,144 | -4,147 | -4,152 | -4,156 | -4,151 | -4,153 | -4,160 | -4,161 | -4,164 | -4,170 | -4,173 | -4,187 | -4,190 | -4,195 | -4,199 | -4,200 | -4,195 | -4,204 | -4,208 | -4,212 |
Additional Paid-In Capital | 0.0% | 4,424 | 4,425 | 4,425 | 4,426 | 4,430 | 4,431 | 4,431 | 4,432 | 4,432 | 4,432 | 4,431 | 4,431 | 4,431 | 4,431 | 4,431 | 4,431 | 4,432 | 4,432 | 4,432 | 4,432 | 4,432 |
Shares Outstanding | -0.1% | 12.00 | 12.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | 13.00 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 58.00 | - | - | - | 64.00 | - | - | - | 61.00 | - | - | - | 43.00 | - | - | - | 36.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -22.3% | 4,430 | 5,700 | 3,799 | 4,724 | 664 | 2,924 | 1,770 | -803 | 4,311 | 11,223 | 3,822 | 14,879 | 4,371 | 10,059 | 4,075 | 1,817 | 3,317 | 5,142 | 2,535 | 3,859 | 7,000 |
Share Based Compensation | -20.7% | 111 | 140 | 170 | 164 | 35.00 | 190 | 59.00 | 166 | 85.00 | 607 | 192 | 187 | 177 | 179 | 179 | 183 | 187 | 193 | 147 | 88.00 | 102 |
Cashflow From Investing | 117.5% | 9,181 | -52,522 | -134 | 14,790 | -11,082 | -15,573 | -36,730 | 14,522 | -5,767 | 15,369 | 8,190 | 7,371 | -5,169 | -26,111 | -4,580 | -92.00 | -4,383 | 1,604 | -25,411 | -15,616 | 12,701 |
Cashflow From Financing | -163.5% | -13,349 | 21,023 | 20,564 | -15,953 | 7,506 | -594 | -759 | - | -8.00 | -2,368 | 8.00 | -17,241 | -600 | 9,746 | -7,348 | -8,876 | 14,226 | -74.00 | -11.00 | -53.00 | -745 |
Buy Backs | 326.9% | 999 | 234 | 963 | 4,599 | 531 | 539 | 599 | - | - | - | - | - | - | 12.00 | 903 | 1,033 | 62.00 | 74.00 | 11.00 | 53.00 | 745 |
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenues: | ||
Finance receivable interest income, including fees | $ 11,454 | $ 9,260 |
Pharmaceutical development | 279 | 118 |
Other | 46 | 33 |
Total revenues | 11,779 | 9,411 |
Costs and expenses: | ||
Provision for credit losses | 5,323 | |
Interest expense | 1,256 | 182 |
Pharmaceutical manufacturing, research and development expense | 530 | 719 |
Depreciation and amortization expense | 514 | 648 |
General and administrative | 2,684 | 2,540 |
Income from operations | 1,472 | 5,322 |
Other income (expense), net | ||
Unrealized net loss on warrants | (95) | (982) |
Loss on exercise of warrants | (143) | |
Realized loss on sale of marketable investments | (231) | |
Gain on foreign currency transactions | 87 | 186 |
Income before income tax expense (benefit) | 1,090 | 4,526 |
Income tax expense (benefit) | 229 | (109) |
Net income | $ 861 | $ 4,635 |
Net income per share | ||
Basic | $ 0.07 | $ 0.36 |
Diluted | $ 0.07 | $ 0.36 |
Basic | 12,475,000 | 12,833,000 |
Diluted | 12,540,000 | 12,875,000 |
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 5,498 | $ 4,503 |
Restricted cash | 733 | |
Interest, accounts receivable and other receivables, net | 6,352 | 4,729 |
Other current assets | 2,086 | 1,904 |
Total current assets | 13,936 | 11,869 |
Finance receivables, net of allowance for credit losses of $13,224 and $13,901 as of March 31, 2024 and December 31, 2023, respectively | 261,285 | 274,504 |
Collateral on foreign currency forward contract | 2,750 | 2,750 |
Marketable investments | 394 | 48 |
Deferred tax assets, net | 28,077 | 28,290 |
Warrant assets | 610 | 1,759 |
Intangible assets, net | 6,198 | 6,487 |
Property and equipment, net | 5,212 | 5,438 |
Other non-current assets | 3,888 | 3,109 |
Total assets | 322,350 | 334,254 |
Current liabilities: | ||
Accounts payable and accrued liabilities | 4,376 | 3,944 |
Total current liabilities | 4,376 | 3,944 |
Contingent consideration payable | 4,900 | 4,900 |
Unsecured senior notes, net | 30,927 | 30,781 |
Revolving credit facility | 12,350 | |
Other non-current liabilities | 1,859 | 1,964 |
Total liabilities | 42,062 | 53,939 |
Stockholders’ equity: | ||
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding | ||
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,481,944 and 12,497,770 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively | 12 | 12 |
Additional paid-in capital | 4,424,216 | 4,425,104 |
Accumulated deficit | (4,143,940) | (4,144,801) |
Total stockholders’ equity | 280,288 | 280,315 |
Total liabilities and stockholders’ equity | $ 322,350 | $ 334,254 |